DNDN DoNeDidN what it had to DoNeDoeN ...this time I gots the target spot on at $25 and "hopefully" they will hold this POS up into the close today. Is DNDN the most groslly overvalued $24 to $25 dallah stock on the planet? Well..can NE1 bring me one that is more grossly overvalued? Lemme know, sheeple. *-) 3J
DNDN is working to get everything that FDA will require to have their prostate drug approved. Before they ask for drug certification dndn will have the cash,factory and employees ready to start production..
DNDN DoNeDidN what it had to DoNeDoeN ...this time I gots the target spot on at $25 and "hopefully" they will hold this POS up into the close today. Is DNDN the most groslly overvalued $24 to $25 dallah stock on the planet? Well..can NE1 bring me one that is more grossly overvalued? Lemme know, sheeple. *-) 3J
Shares of the Dendreon Corp. (DNDN) behaved pretty well during their first two round trips in the P&P portfolio, and I suspect they may perform OK over the next week or so, as well. Details of Dendreon's IMmunotherapy for Prostate AdenoCarcinoma Treatment (IMPACT) Phase 3 clinical trial of Provenge will be presented during a plenary session at the American Urological Association's annual meeting on Apr 28 at 3:20 pm ET.
Rated #1 best-performing stock newsletter over the past 10 years by independent Hulbert Financial Digest. Zacks Elite gives you full access to the power of the Zacks Rank, plus the private, hand picked Focus List, Timely Buys and Growth & Income Portfolios. Start a Free Trial Today >>
Find Winning Stocks Quickly with Research Wizard, a powerful desktop software program. Start with easy-to-use pre-loaded strategies, then develop your own. Backtest against years of historical data to see how your approach works in any market. Start a Free Trial Today >>
With Zacks Method for Trading you'll transform yourself into a Master Stock Trader, one simple step at a time. Get step-by-step instructions and learn how to use the 26% per year Zacks Rank system to find market-beating stocks on your own, fully exploiting the system that beat the market 18 of the last 20 years. Find out how >>
Built upon the legendary performance of the original sold-out trading service, Value Trader 2 combines traditional value investing signals with the timeliness of the Zacks Rank to drive striking performance in Bull and Bear periods. We tested this strategy against the bear period of 2000-2002 when the S&P 500 lost -14.7% per year. Then we honed a strategy for Value Trader 2 that averaged an astounding yearly gain of +41.3%. Learn More >>
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 3 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 19 | Comment
Comments: 0 | Comment